मलाशय का कैंसर (Rectal cancer)
To see the safety and effectiveness of Nuvastatic® 300mg capsule in fatigue who are receiving chemotherapy with patients suffering with colorectal cancer
हॉस्पिटल से संपर्क करें
रजिस्ट्री में इस hospital को trial के main contact के तौर पर दिखाया गया है। उनसे पूछिए कि कौन-कौन से hospital मरीज़ों को ले रहे हैं।
रजिस्ट्री समरी (तकनीकी)
A randomized double blind placebo controlled parallel group comparative phase III study to evaluate the efficacy and safety of Nuvastatic® 300mg in reducing cancerinduced fatigue in patients with newly diagnosed chemotherapy naïve nonresectable metastatic colorectal cancer receiving standard chemotherapy - NIL
Sponsor: Natureceuticals Sdn Bhd
CTRI, India's trial registry पर CTRI/2024/11/076297
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, 12 Oct 2026 का data
Registry पर last updated 27 Apr 2026 · read by us 5 Nov 2026